Foghorn therapeutics stock
WebStock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. Print. RSS Feeds. Email Alerts. Investor Contact. Search. © 2024 Foghorn Therapeutics. WebApr 10, 2024 · CAMBRIDGE, Apr 10, 2024 (GLOBE NEWSWIRE via COMTEX) -- CAMBRIDGE, Mass., April 10, 2024 (GLOBE NEWSWIRE) -- Foghorn (R) Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company ...
Foghorn therapeutics stock
Did you know?
WebApr 11, 2024 · Foghorn Therapeutics Inc. Stock Price History. Foghorn Therapeutics Inc.’s price is currently up 0.65% so far this month. During the month of April, Foghorn Therapeutics Inc.’s stock price has reached a high of $6.34 and a low of $5.63. Over the last year, Foghorn Therapeutics Inc. has hit prices as high as $18.12 and as low as … WebView the latest Foghorn Therapeutics Inc. (FHTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.
WebApr 10, 2024 · CAMBRIDGE, Mass., April 10, 2024 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that preclinical data from two of its protein degrader programs, … WebApr 5, 2024 · Foghorn Therapeutics ( NASDAQ: FHTX) is a prime example of what happens when preclinical stage companies launch IPOs without clinical data. In India we have this real estate business where...
WebGet the latest Foghorn Therapeutics Inc. (FHTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … WebApr 10, 2024 · April 10, 2024 - 4:05 pm. CAMBRIDGE, Mass., April 10, 2024 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage …
WebMar 31, 2024 · According to analysts, Foghorn Therapeutics's stock has a predicted upside of 163.35% based on their 12-month price targets. What analysts cover Foghorn …
WebMar 9, 2024 · Foghorn Therapeutics Inc. (FHTX Quick Quote FHTX - Free Report) came out with a quarterly loss of $0.69 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to loss of ... bry smithWebApr 11, 2024 · According to analysts' consensus price target of $18.33, Foghorn Therapeutics has a forecasted upside of 195.7% from its current price of $6.20. Amount … bryson 5 piece wayfairWebFoghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for … bryson 800 best loadoutWebA New Class of Therapeutics. Foghorn is pioneering a new class of medicines that treat serious disease by correcting abnormal gene expression. These precision therapeutic candidates target disease … brys marysville washingtonWebApr 5, 2024 · Foghorn Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. More... Sector Health Care Industry Biotechnology … excel header row on every pageWebThe 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Foghorn Therapeutics Inc 50-day moving average is $6.19. bryson 800 multiplayer buildWebDec 5, 2024 · CAMBRIDGE, Mass., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious ... bryson 800 real life